Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation (Q27656338)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation |
scientific article |
Statements
Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation (English)
Alejandro López-Requena
1 reference
Ariel Talavera
Silvia Gómez-Puerta
Carlos Martinez-Fleites
Greta Garrido
Ailem Rabasa
Rune F Johansen
Oliberto Sánchez
1 reference
Identifiers
2 references
2 references